Cindyoxy的个人主页 - 老虎社区

Cindyoxy

Cindyoxy

暂无个人介绍

IP属地：未知

6关注

5粉丝

0主题

0勋章

2021-10-19

Like pls

After-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more

2021-10-15

Please like. Thanks

抱歉，原内容已删除

2021-11-03

Please like. Thanks

Nvidia shares rose more than 2% to a new high

2021-10-29

Please like, thank you

Amazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3582080374471215,"uuid":"3582080374471215","gmtCreate":1618987725659,"gmtModify":1634306747887,"name":"Cindyoxy","pinyin":"cindyoxy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":6,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":841609274,"gmtCreate":1635904171931,"gmtModify":1635904185510,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like. Thanks","listText":"Please like. Thanks","text":"Please like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841609274","repostId":"1101901401","repostType":4,"repost":{"id":"1101901401","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635866554,"share":"https://www.laohu8.com/m/news/1101901401?lang=&edition=full","pubTime":"2021-11-02 23:22","market":"us","language":"en","title":"Nvidia shares rose more than 2% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1101901401","media":"Tiger Newspress","summary":"Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 bill","content":"<p>Nvidia shares rose more than 2% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/cba7404008cd93258b0ffcb352a81ce2\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.</p>\n<p>NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.</p>\n<p>Investors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares rose more than 2% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares rose more than 2% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 23:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia shares rose more than 2% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/cba7404008cd93258b0ffcb352a81ce2\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.</p>\n<p>NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.</p>\n<p>Investors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101901401","content_text":"Nvidia shares rose more than 2% to a new high.\n\nWall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.\nNVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.\nInvestors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.","news_type":1},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857042949,"gmtCreate":1635498822356,"gmtModify":1635498985971,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like, thank you&nbsp;","listText":"Please like, thank you&nbsp;","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857042949","repostId":"1103014145","repostType":4,"repost":{"id":"1103014145","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635494639,"share":"https://www.laohu8.com/m/news/1103014145?lang=&edition=full","pubTime":"2021-10-29 16:03","market":"us","language":"en","title":"Amazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1103014145","media":"Tiger Newspress","summary":"Amazon slid more than 4% in premarket trading as itmissed sales estimates for the second straight qu","content":"<p>Amazon slid more than 4% in premarket trading as itmissed&nbsp;sales estimates for the second straight quarter.<img src=\"https://static.tigerbbs.com/1be5084c916792ce4eb7e2f73b8bfc23\" tg-width=\"771\" tg-height=\"569\" width=\"100%\" height=\"auto\">According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.</p>\n<p>Its&nbsp;Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.</p>\n<p>Among them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-29 16:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amazon slid more than 4% in premarket trading as itmissed&nbsp;sales estimates for the second straight quarter.<img src=\"https://static.tigerbbs.com/1be5084c916792ce4eb7e2f73b8bfc23\" tg-width=\"771\" tg-height=\"569\" width=\"100%\" height=\"auto\">According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.</p>\n<p>Its&nbsp;Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.</p>\n<p>Among them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103014145","content_text":"Amazon slid more than 4% in premarket trading as itmissed sales estimates for the second straight quarter.According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.\nIts Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.\nAmong them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850549704,"gmtCreate":1634610961478,"gmtModify":1634610961603,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/850549704","repostId":"2176774120","repostType":4,"repost":{"id":"2176774120","pubTimestamp":1634599410,"share":"https://www.laohu8.com/m/news/2176774120?lang=&edition=full","pubTime":"2021-10-19 07:23","market":"us","language":"en","title":"After-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176774120","media":"StreetInsider","summary":"After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ETTX\">Entasis Therapeutics Holdings Inc.</a> (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by Acinetobacter baumannii. SUL-DUR met the primary endpoint of 28-day all-cause mortality in patients with carbapenem-resistant Acinetobacter infections (CRABC m-MITT* population in Part A of the study), demonstrating statistical non-inferiority versus colistin. Mortality analyses favored SUL-DUR versus colistin in CRABC m-MITT and all study populations included in the topline results. At Test of Cure, there was a statistically significant difference in clinical response favoring SUL-DUR over colistin. SUL-DUR met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity.</p>\n<p><a href=\"https://laohu8.com/S/DRMAW\">Dermata Therapeutics, Inc.</a> (NASDAQ: DRMA) 13.4% HIGHER; announced positive topline results from its Phase 1b trial of DMT310 in 30 patients as a once-weekly topical application for the treatment of mild-to-moderate psoriasis. DMT310 is Dermata's lead product candidate, with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including acne, psoriasis, and rosacea.</p>\n<p>TaskUs, Inc. (NASDAQ: TASK) 6.5% LOWER; announced today that certain of its stockholders have commenced an underwritten public offering of 10,000,000 shares of TaskUs Class A common stock. In connection with the offering, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Class A common stock.</p>\n<p>EverQuote, Inc. (Nasdaq: EVER) 5.6% LOWER; Total revenue is expected to be in the range of $106.5 $107.5 million, compared to guidance of $109 - $111 million.</p>\n<p><a href=\"https://laohu8.com/S/STLD\">Steel Dynamics</a> (NASDAQ: STLD) 1.6% HIGHER; Q3 results, with EPS coming in at $4.96, beating the consensus estimate of $4.57. Quarterly revenue was a record $5.1 billion (vs. $2.3 billion in Q3/20), better than the consensus estimate of $4.98 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-19 07:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19073229><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19073229\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TASK":"TaskUs Inc.","STLD":"Steel Dynamics","EVER":"Everquote Inc.","DRMA":"Dermata Therapeutics Inc","ETTX":"Entasis Therapeutics Holdings Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19073229","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176774120","content_text":"After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by Acinetobacter baumannii. SUL-DUR met the primary endpoint of 28-day all-cause mortality in patients with carbapenem-resistant Acinetobacter infections (CRABC m-MITT* population in Part A of the study), demonstrating statistical non-inferiority versus colistin. Mortality analyses favored SUL-DUR versus colistin in CRABC m-MITT and all study populations included in the topline results. At Test of Cure, there was a statistically significant difference in clinical response favoring SUL-DUR over colistin. SUL-DUR met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity.\nDermata Therapeutics, Inc. (NASDAQ: DRMA) 13.4% HIGHER; announced positive topline results from its Phase 1b trial of DMT310 in 30 patients as a once-weekly topical application for the treatment of mild-to-moderate psoriasis. DMT310 is Dermata's lead product candidate, with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including acne, psoriasis, and rosacea.\nTaskUs, Inc. (NASDAQ: TASK) 6.5% LOWER; announced today that certain of its stockholders have commenced an underwritten public offering of 10,000,000 shares of TaskUs Class A common stock. In connection with the offering, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Class A common stock.\nEverQuote, Inc. (Nasdaq: EVER) 5.6% LOWER; Total revenue is expected to be in the range of $106.5 $107.5 million, compared to guidance of $109 - $111 million.\nSteel Dynamics (NASDAQ: STLD) 1.6% HIGHER; Q3 results, with EPS coming in at $4.96, beating the consensus estimate of $4.57. Quarterly revenue was a record $5.1 billion (vs. $2.3 billion in Q3/20), better than the consensus estimate of $4.98 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":413,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824846666,"gmtCreate":1634305213573,"gmtModify":1634305279432,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like. Thanks","listText":"Please like. Thanks","text":"Please like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/824846666","repostId":"1118158641","repostType":4,"repost":{"id":"1118158641","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1634304742,"share":"https://www.laohu8.com/m/news/1118158641?lang=&edition=full","pubTime":"2021-10-15 21:32","market":"us","language":"en","title":"Dow adds 200 points following earnings beats, surprise retail sales gain","url":"https://stock-news.laohu8.com/highlight/detail?id=1118158641","media":"Tiger Newspress","summary":"U.S. stock indexes rose on Friday as better-than-expected third-quarter earnings reports set the S&P","content":"<p>U.S. stock indexes rose on Friday as better-than-expected third-quarter earnings reports set the S&amp;P 500 on track for a winning week.</p>\n<p>The Dow Jones Industrial Average gained about 200 points, or 0.6%. S&amp;P 500 futures added 0.5% and Nasdaq 100 futures rose 0.5%.</p>\n<p><img src=\"https://static.tigerbbs.com/48f7dc7debfcaa75b7e218cca2a48bbd\" tg-width=\"1041\" tg-height=\"369\" referrerpolicy=\"no-referrer\"></p>\n<p>Earnings momentum continued Friday as&nbsp;Goldman Sachs' third-quarter results&nbsp;beat significantly on the top and bottom line. The bank stock gained more than 1%.</p>\n<p>The stellar report came after earnings beats from other big banks earlier in the week. Financial heavyweights JPMorgan, Bank of America, Morgan Stanley and Citigroup were among the firms topping expectations.</p>\n<p>Moderna added 2% in morning trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.</p>\n<p>Retail sales posted a&nbsp;surprise increase&nbsp;in September, rising 0.7%. Economists polled by Dow Jones were expecting a 0.2% decline.</p>\n<p>Virgin Galactic shares tumbled 14%&nbsp;after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow adds 200 points following earnings beats, surprise retail sales gain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow adds 200 points following earnings beats, surprise retail sales gain\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-15 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock indexes rose on Friday as better-than-expected third-quarter earnings reports set the S&amp;P 500 on track for a winning week.</p>\n<p>The Dow Jones Industrial Average gained about 200 points, or 0.6%. S&amp;P 500 futures added 0.5% and Nasdaq 100 futures rose 0.5%.</p>\n<p><img src=\"https://static.tigerbbs.com/48f7dc7debfcaa75b7e218cca2a48bbd\" tg-width=\"1041\" tg-height=\"369\" referrerpolicy=\"no-referrer\"></p>\n<p>Earnings momentum continued Friday as&nbsp;Goldman Sachs' third-quarter results&nbsp;beat significantly on the top and bottom line. The bank stock gained more than 1%.</p>\n<p>The stellar report came after earnings beats from other big banks earlier in the week. Financial heavyweights JPMorgan, Bank of America, Morgan Stanley and Citigroup were among the firms topping expectations.</p>\n<p>Moderna added 2% in morning trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.</p>\n<p>Retail sales posted a&nbsp;surprise increase&nbsp;in September, rising 0.7%. Economists polled by Dow Jones were expecting a 0.2% decline.</p>\n<p>Virgin Galactic shares tumbled 14%&nbsp;after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118158641","content_text":"U.S. stock indexes rose on Friday as better-than-expected third-quarter earnings reports set the S&P 500 on track for a winning week.\nThe Dow Jones Industrial Average gained about 200 points, or 0.6%. S&P 500 futures added 0.5% and Nasdaq 100 futures rose 0.5%.\n\nEarnings momentum continued Friday as Goldman Sachs' third-quarter results beat significantly on the top and bottom line. The bank stock gained more than 1%.\nThe stellar report came after earnings beats from other big banks earlier in the week. Financial heavyweights JPMorgan, Bank of America, Morgan Stanley and Citigroup were among the firms topping expectations.\nModerna added 2% in morning trading after rising 3.2% yesterday, following an FDA panel recommendation for a booster dose of its Covid-19 vaccine. The panel recommended approval of a booster for people 65 and over as well as those at high risk.\nRetail sales posted a surprise increase in September, rising 0.7%. Economists polled by Dow Jones were expecting a 0.2% decline.\nVirgin Galactic shares tumbled 14% after it said it would delay the launch of its commercial space service to the fourth quarter of 2022 from the third quarter. The company is taking the extra time to work on improvements to its space vehicles.","news_type":1},"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":850549704,"gmtCreate":1634610961478,"gmtModify":1634610961603,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/850549704","repostId":"2176774120","repostType":4,"repost":{"id":"2176774120","pubTimestamp":1634599410,"share":"https://www.laohu8.com/m/news/2176774120?lang=&edition=full","pubTime":"2021-10-19 07:23","market":"us","language":"en","title":"After-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2176774120","media":"StreetInsider","summary":"After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/ETTX\">Entasis Therapeutics Holdings Inc.</a> (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by Acinetobacter baumannii. SUL-DUR met the primary endpoint of 28-day all-cause mortality in patients with carbapenem-resistant Acinetobacter infections (CRABC m-MITT* population in Part A of the study), demonstrating statistical non-inferiority versus colistin. Mortality analyses favored SUL-DUR versus colistin in CRABC m-MITT and all study populations included in the topline results. At Test of Cure, there was a statistically significant difference in clinical response favoring SUL-DUR over colistin. SUL-DUR met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity.</p>\n<p><a href=\"https://laohu8.com/S/DRMAW\">Dermata Therapeutics, Inc.</a> (NASDAQ: DRMA) 13.4% HIGHER; announced positive topline results from its Phase 1b trial of DMT310 in 30 patients as a once-weekly topical application for the treatment of mild-to-moderate psoriasis. DMT310 is Dermata's lead product candidate, with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including acne, psoriasis, and rosacea.</p>\n<p>TaskUs, Inc. (NASDAQ: TASK) 6.5% LOWER; announced today that certain of its stockholders have commenced an underwritten public offering of 10,000,000 shares of TaskUs Class A common stock. In connection with the offering, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Class A common stock.</p>\n<p>EverQuote, Inc. (Nasdaq: EVER) 5.6% LOWER; Total revenue is expected to be in the range of $106.5 $107.5 million, compared to guidance of $109 - $111 million.</p>\n<p><a href=\"https://laohu8.com/S/STLD\">Steel Dynamics</a> (NASDAQ: STLD) 1.6% HIGHER; Q3 results, with EPS coming in at $4.96, beating the consensus estimate of $4.57. Quarterly revenue was a record $5.1 billion (vs. $2.3 billion in Q3/20), better than the consensus estimate of $4.98 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Entasis Therapeutics,Dermata Therapeutics,TaskUs and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-19 07:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19073229><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19073229\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TASK":"TaskUs Inc.","STLD":"Steel Dynamics","EVER":"Everquote Inc.","DRMA":"Dermata Therapeutics Inc","ETTX":"Entasis Therapeutics Holdings Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19073229","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2176774120","content_text":"After-Hours Stock Movers:\nEntasis Therapeutics Holdings Inc. (Nasdaq: ETTX) 22.2% HIGHER; announced topline results from its ATTACK triala global Phase 3 registrational trial evaluating the safety and efficacy of SUL-DUR versus colistin in patients with infections caused by Acinetobacter baumannii. SUL-DUR met the primary endpoint of 28-day all-cause mortality in patients with carbapenem-resistant Acinetobacter infections (CRABC m-MITT* population in Part A of the study), demonstrating statistical non-inferiority versus colistin. Mortality analyses favored SUL-DUR versus colistin in CRABC m-MITT and all study populations included in the topline results. At Test of Cure, there was a statistically significant difference in clinical response favoring SUL-DUR over colistin. SUL-DUR met the primary safety objective of the study achieving statistically significant reduction in nephrotoxicity.\nDermata Therapeutics, Inc. (NASDAQ: DRMA) 13.4% HIGHER; announced positive topline results from its Phase 1b trial of DMT310 in 30 patients as a once-weekly topical application for the treatment of mild-to-moderate psoriasis. DMT310 is Dermata's lead product candidate, with both mechanical and chemical mechanisms of action, currently being investigated to treat multiple inflammatory skin conditions, including acne, psoriasis, and rosacea.\nTaskUs, Inc. (NASDAQ: TASK) 6.5% LOWER; announced today that certain of its stockholders have commenced an underwritten public offering of 10,000,000 shares of TaskUs Class A common stock. In connection with the offering, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Class A common stock.\nEverQuote, Inc. (Nasdaq: EVER) 5.6% LOWER; Total revenue is expected to be in the range of $106.5 $107.5 million, compared to guidance of $109 - $111 million.\nSteel Dynamics (NASDAQ: STLD) 1.6% HIGHER; Q3 results, with EPS coming in at $4.96, beating the consensus estimate of $4.57. Quarterly revenue was a record $5.1 billion (vs. $2.3 billion in Q3/20), better than the consensus estimate of $4.98 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":413,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824846666,"gmtCreate":1634305213573,"gmtModify":1634305279432,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like. Thanks","listText":"Please like. Thanks","text":"Please like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/824846666","repostId":"1118158641","repostType":4,"isVote":1,"tweetType":1,"viewCount":775,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841609274,"gmtCreate":1635904171931,"gmtModify":1635904185510,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like. Thanks","listText":"Please like. Thanks","text":"Please like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841609274","repostId":"1101901401","repostType":4,"repost":{"id":"1101901401","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635866554,"share":"https://www.laohu8.com/m/news/1101901401?lang=&edition=full","pubTime":"2021-11-02 23:22","market":"us","language":"en","title":"Nvidia shares rose more than 2% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1101901401","media":"Tiger Newspress","summary":"Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 bill","content":"<p>Nvidia shares rose more than 2% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/cba7404008cd93258b0ffcb352a81ce2\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.</p>\n<p>NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.</p>\n<p>Investors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia shares rose more than 2% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia shares rose more than 2% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-02 23:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nvidia shares rose more than 2% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/cba7404008cd93258b0ffcb352a81ce2\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Wall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.</p>\n<p>NVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.</p>\n<p>Investors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101901401","content_text":"Nvidia shares rose more than 2% to a new high.\n\nWall Street will be looking for positivity from NVDA as it approaches its next earnings report date. This is expected to be November 17, 2021. In that report, analysts expect NVDA to post earnings of $1.11 per share. This would mark year-over-year growth of 52.05%. Our most recent consensus estimate is calling for quarterly revenue of $6.83 billion, up 44.46% from the year-ago period.\nNVDA's full-year Zacks Consensus Estimates are calling for earnings of $4.14 per share and revenue of $25.84 billion. These results would represent year-over-year changes of +65.6% and +54.96%, respectively.\nInvestors might also notice recent changes to analyst estimates for NVDA. These revisions help to show the ever-changing nature of near-term business trends.","news_type":1},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857042949,"gmtCreate":1635498822356,"gmtModify":1635498985971,"author":{"id":"3582080374471215","authorId":"3582080374471215","name":"Cindyoxy","avatar":"https://static.tigerbbs.com/6ce8843c8a2fd64a899130762430331d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Please like, thank you&nbsp;","listText":"Please like, thank you&nbsp;","text":"Please like, thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857042949","repostId":"1103014145","repostType":4,"repost":{"id":"1103014145","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635494639,"share":"https://www.laohu8.com/m/news/1103014145?lang=&edition=full","pubTime":"2021-10-29 16:03","market":"us","language":"en","title":"Amazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1103014145","media":"Tiger Newspress","summary":"Amazon slid more than 4% in premarket trading as itmissed sales estimates for the second straight qu","content":"<p>Amazon slid more than 4% in premarket trading as itmissed&nbsp;sales estimates for the second straight quarter.<img src=\"https://static.tigerbbs.com/1be5084c916792ce4eb7e2f73b8bfc23\" tg-width=\"771\" tg-height=\"569\" width=\"100%\" height=\"auto\">According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.</p>\n<p>Its&nbsp;Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.</p>\n<p>Among them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon slid more than 4% in premarket trading as it missed sales estimates for the second straight quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-29 16:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amazon slid more than 4% in premarket trading as itmissed&nbsp;sales estimates for the second straight quarter.<img src=\"https://static.tigerbbs.com/1be5084c916792ce4eb7e2f73b8bfc23\" tg-width=\"771\" tg-height=\"569\" width=\"100%\" height=\"auto\">According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.</p>\n<p>Its&nbsp;Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.</p>\n<p>Among them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103014145","content_text":"Amazon slid more than 4% in premarket trading as itmissed sales estimates for the second straight quarter.According to the financial report,itssalesinthe third quarterrose 12% to $110.8 billion, compared with $96.1 billion in the second quarter of 2020. The figure was lower than Wall Street's previous forecast of $111.81 billion in net sales, and was thought to be the result of slowing growth after the surge in online shopping.\nIts Net profit was US $3.2 billion, down 50.2% from US $6.3 billion in the same period last year.\nAmong them, product sales were US $54.88 billion, up 4% year-on-year, and service sales were US $55.93 billion, up 29% year-on-year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}